X-9894391-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2
The NM_001649.4(SHROOM2):c.483G>A(p.Glu161Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00229 in 1,208,313 control chromosomes in the GnomAD database, including 54 homozygotes. There are 737 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.012 ( 29 hom., 352 hem., cov: 23)
Exomes 𝑓: 0.0013 ( 25 hom. 385 hem. )
Consequence
SHROOM2
NM_001649.4 synonymous
NM_001649.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.968
Genes affected
SHROOM2 (HGNC:630): (shroom family member 2) This gene represents the human homolog of Xenopus laevis apical protein (APX) gene, which is implicated in amiloride-sensitive sodium channel activity. It is expressed in endothelial cells and facilitates the formation of a contractile network within endothelial cells. Depletion of this gene results in an increase in endothelial sprouting, migration, and angiogenesis. This gene is highly expressed in the retina, and is a strong candidate for ocular albinism type 1 syndrome. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant X-9894391-G-A is Benign according to our data. Variant chrX-9894391-G-A is described in ClinVar as [Benign]. Clinvar id is 3042208.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chrX-9894391-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.968 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.012 (1341/111376) while in subpopulation AFR AF= 0.0414 (1267/30608). AF 95% confidence interval is 0.0395. There are 29 homozygotes in gnomad4. There are 352 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 29 gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0120 AC: 1337AN: 111325Hom.: 28 Cov.: 23 AF XY: 0.0105 AC XY: 352AN XY: 33543
GnomAD3 genomes
AF:
AC:
1337
AN:
111325
Hom.:
Cov.:
23
AF XY:
AC XY:
352
AN XY:
33543
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00334 AC: 604AN: 180748Hom.: 10 AF XY: 0.00228 AC XY: 150AN XY: 65656
GnomAD3 exomes
AF:
AC:
604
AN:
180748
Hom.:
AF XY:
AC XY:
150
AN XY:
65656
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00130 AC: 1424AN: 1096937Hom.: 25 Cov.: 32 AF XY: 0.00106 AC XY: 385AN XY: 362429
GnomAD4 exome
AF:
AC:
1424
AN:
1096937
Hom.:
Cov.:
32
AF XY:
AC XY:
385
AN XY:
362429
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0120 AC: 1341AN: 111376Hom.: 29 Cov.: 23 AF XY: 0.0105 AC XY: 352AN XY: 33604
GnomAD4 genome
AF:
AC:
1341
AN:
111376
Hom.:
Cov.:
23
AF XY:
AC XY:
352
AN XY:
33604
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
SHROOM2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 28, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at